AstraZeneca’s Oral SERD Etcamah Fails Key First-Line Breast Cancer Trial, Raising Questions for Broader Market Ambitions
AstraZeneca, the Anglo-Swedish pharmaceutical giant, announced on Friday, September 14, 2026, a significant setback for...
Knowledge and News for the Global Fight Against Cancer.
AstraZeneca, the Anglo-Swedish pharmaceutical giant, announced on Friday, September 14, 2026, a significant setback for...
For decades, lung cancer has been inextricably linked with tobacco smoking, a connection deeply rooted...
The Cancer Research Institute (CRI) has reaffirmed its profound commitment to advancing cancer immunotherapy by...
The Cancer Research Institute (CRI) has recognized Dr. Aaron Whiteley, an Assistant Professor in the...
This World Cancer Support Month, communities worldwide are turning their focus to the often-unseen heroes...
Cancer, a disease often perceived as a sudden onset, in reality, embarks on a clandestine...
A flurry of significant developments across the biopharmaceutical landscape has captured industry attention this week,...
The biopharmaceutical industry is currently navigating a complex and highly dynamic period, characterized by contrasting...
The cancer vaccine field experienced a significant leap forward last month when the personalized melanoma...
For decades, the ambitious vision of training a patient’s own immune system to specifically target...